Traumeric Capsules
Traumeric Capsules, licence 80105226: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Traumeric
- Licence holder
- Ortho Molecular Products Inc.
- NPN or DIN-HM
- 80105226
- Status
- Active licence
- Licence date
- 14 October 2020
- Revision date
- 24 June 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Stem bromelain Source : Ananas comosus var. comosus - Tige | 4320000.0 FCC PU | Not calculated |
| Stem bromelain Source : Ananas comosus var. comosus - Tige | 120.0 mg | Not calculated |
| Curcuma longa Source : Rhizome Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 8250 mg Potency : 50.0 % Curcuminoids | 330.0 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 15.0 mg | 15,000 µg |
| 3,3',4',5,7-Pentahydroxyflavone-3-rutinoside Source : Styphnolobium japonicum - Bourgeon floral | 25.0 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Stéarate de magnésium, Hypromellose, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Source of/Provides antioxidants. Helps (to) maintain/support immune function. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Helps in connective tissue formation. Helps in the development and maintenance of bones, cartilage, teeth and/or gums. Helps in the development and maintenance of bones, cartilage, teeth and/or gums and in connective tissue formation. Helps in wound healing. Helps with immune function. Source of/An antioxidant for the maintenance of good health. Source of/An antioxidant that helps fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Digestive enzyme. Used in herbal medicine to help relieve minor pain, swelling and inflammation. Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80105226
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.